XML 24 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
OPERATING CASH FLOW      
Net earnings $ 2,084,000 $ 79,000 $ 73,000
Adjustments to reconcile net earnings to operating cash flow:      
Equity method earnings (2,105,000) 0 0
Impairment 0 0 (24,000)
Gain on pension settlement 0 0 (42,000)
Depreciation and amortization 73,000 74,000 73,000
(Gain) loss on sales of assets (including Stork and AMECO) (14,000) 150,000 (35,000)
Stock-based compensation 31,000 48,000 19,000
Deferred taxes 418,000 (13,000) 17,000
Changes in assets and liabilities 347,000 (114,000) (46,000)
Other (6,000) (12,000) (4,000)
Operating cash flow 828,000 212,000 31,000
INVESTING CASH FLOW      
Purchases of marketable securities (205,000) (426,000) (428,000)
Proceeds from sales and maturities of marketable securities 145,000 285,000 364,000
Capital expenditures (164,000) (106,000) (75,000)
NuScale cash deconsolidated (131,000) 0 0
Proceeds from sales of assets (net of cash divested) 82,000 (5,000) 95,000
Investments in partnerships and joint ventures (93,000) (33,000) (53,000)
Return of capital from partnerships and joint ventures 34,000 8,000 19,000
Investing cash flow (333,000) (277,000) (78,000)
FINANCING CASH FLOW      
Repurchase of common stock (125,000) 0 0
Proceeds from issuance of 2029 Notes, net of issuance costs 0 560,000 0
Capped call transactions related to 2029 Notes 0 (73,000) 0
Purchases and retirement of debt (57,000) (249,000) (41,000)
Proceeds from NuScale de-SPAC transaction 0 0 341,000
Proceeds from sale of NuScale interest 80,000 0 107,000
Dividends paid on CPS 0 (29,000) (39,000)
Make-whole payment on conversion of CPS 0 (27,000) 0
Distributions paid to NCI (14,000) (53,000) (60,000)
Capital contributions by NCI 0 10,000 21,000
Other 0 (12,000) (14,000)
Financing cash flow (116,000) 127,000 315,000
Effect of exchange rate changes on cash (69,000) 18,000 (38,000)
Increase in cash and cash equivalents 310,000 80,000 230,000
Cash and cash equivalents at beginning of year 2,519,000 2,439,000 2,209,000
Cash and cash equivalents at end of year $ 2,829,000 $ 2,519,000 $ 2,439,000